Lindsay Yount King
Assistant Professor of Medicine
Current Appointments & Affiliations
- Assistant Professor of Medicine, Medicine, Gastroenterology, Medicine 2021
Contact Information
- Background
-
Education, Training, & Certifications
- Advanced Transplant Hepatology Fellowship, Medicine, Massachusetts General Hospital 2014 - 2015
- Clinical & Research Fellowship in Gastroenterology, Medicine, Massachusetts General Hospital 2010 - 2014
- M.P.H., Harvard University 2014
- Internal Medicine Residency, Medicine, Brigham and Women's Hospital 2006 - 2009
- M.D., University of Virginia School of Medicine 2006
-
Previous Appointments & Affiliations
- Assistant Professor of Medicine, Medicine, Gastroenterology, Medicine 2015 - 2020
- Research
-
Selected Grants
- TARGET-PBC A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis awarded by Target Corporation 2017 - 2023
- IM101-823 - Abatacept for treatment of recurrent or de novo autoimmune hepatitis awarded by The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership 2019 - 2021
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Moon, Andrew M., Zachary Spiritos, Lindsay Y. King, and A Sidney Barritt. “Immunosuppression in Autoimmune Hepatitis: Is There an End Game?” Am J Gastroenterol 115, no. 4 (April 2020): 498–501. https://doi.org/10.14309/ajg.0000000000000538.Full Text Link to Item
-
Shropshire, Erin L., Mohammad Chaudhry, Chad M. Miller, Brian C. Allen, Erol Bozdogan, Diana M. Cardona, Lindsay Y. King, et al. “LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.” Radiology 292, no. 1 (July 2019): 226–34. https://doi.org/10.1148/radiol.2019182135.Full Text Link to Item
-
Patel, Yuval A., Kara Wegermann, Carl L. Berg, and Lindsay Y. King. “Patient 1 with decompensated nonalcoholic steatohepatitis cirrhosis with inability to lose weight should undergo transplantation.” Clin Liver Dis (Hoboken) 11, no. 6 (June 2018): 149–51. https://doi.org/10.1002/cld.703.Full Text Link to Item
-
Simon, Tracey G., Lindsay Y. King, Dawn Q. Chong, Long H. Nguyen, Yanan Ma, Trang VoPham, Edward L. Giovannucci, et al. “Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.” Hepatology 67, no. 5 (May 2018): 1797–1806. https://doi.org/10.1002/hep.29660.Full Text Link to Item
-
Henson, Jacqueline B., Yuval A. Patel, Julius M. Wilder, Jiayin Zheng, Shein-Chung Chow, Lindsay Y. King, and Andrew J. Muir. “Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.” Dig Dis Sci 62, no. 11 (November 2017): 3200–3209. https://doi.org/10.1007/s10620-017-4559-1.Full Text Link to Item
-
Henson, Jacqueline B., Yuval A. Patel, Lindsay Y. King, Jiayin Zheng, Shein-Chung Chow, and Andrew J. Muir. “Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.” Liver Transpl 23, no. 6 (June 2017): 769–80. https://doi.org/10.1002/lt.24703.Full Text Link to Item
-
Peloquin, Joanna M., Siamak M. Seraj, Lindsay Y. King, Emily J. Campbell, Ashwin N. Ananthakrishnan, and James M. Richter. “Diagnostic and Therapeutic Yield of Endoscopy in Patients with Elevated INR and Gastrointestinal Bleeding.” Am J Med 129, no. 6 (June 2016): 628–34. https://doi.org/10.1016/j.amjmed.2015.11.030.Full Text Link to Item
-
Mueller, Jessica L., Lindsay Y. King, Kara B. Johnson, Tian Gao, Lauren D. Nephew, Darshan Kothari, Mary Ann Simpson, et al. “Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.” Clin Transplant 30, no. 4 (April 2016): 452–60. https://doi.org/10.1111/ctr.12710.Full Text Link to Item
-
-
Conference Papers
-
Ma, Yanan, Tracey G. Simon, Fred K. Tabung, Lindsay Y. King, Dawn Q. Chong, Long Nguyen, Trang VoPham, et al. “Abstract 5256: A prospective study of inflammatory diet potential and risk of hepatocellular carcinoma (HCC).” In Cancer Research, 78:5256–5256. American Association for Cancer Research (AACR), 2018. https://doi.org/10.1158/1538-7445.am2018-5256.Full Text
-
Simon, Tracey G., Lindsay Y. King, Dawn Q. Chong, Yanan Ma, Hamed Khalili, Raymond T. Chung, Xuehong Zhang, and Andrew T. Chan. “Diabetes, duration of diabetes, use of anti-diabetic medications, and risk of hepatocellular carcinoma.” In Hepatology, 66:759A-760A. WILEY, 2017.Link to Item
-
Goossens, Nicolas, Amit G. Singal, Lindsay Y. King, Karin L. Andersson, Bryan C. Fuchs, Cecilia Besa, Bachir Taouli, Raymond T. Chung, and Yujin Hoshida. “Cost-effectiveness of a risk-stratified hepatocellular carcinoma surveillance strategy in patients with cirrhosis.” In Hepatology, 64:630A-630A. WILEY, 2016.Link to Item
-
Henson, Jacqueline B., Julius M. Wilder, Yuval A. Patel, Jiayin Zheng, Shein-Chung Chow, Lindsay Y. King, and Andrew J. Muir. “Phenotypic Differences in Primary Sclerosing Cholangitis by Age Group.” In Hepatology, 64:185A-185A. WILEY, 2016.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.